SEER, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
SEER, INC. (SEER) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $1.78 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-11
- SEER, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $1.79.
- SEER, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- SEER, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $2.20, a 44.72% decline year-over-year.
- SEER, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2022-03-31 was $3.98, a 804.55% increase year-over-year.
- SEER, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $1.98.
- SEER, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- SEER, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $0.52, a 83.85% decline from fiscal 2022.
- SEER, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $3.22, a 75.00% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.78 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | $1.79 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $1.98 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $2.03 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $2.08 10-Q · filed 2025-08-06 | |||
| 2024-12-31 | $0.00 10-K · filed 2025-03-03 | |||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | $0.52 10-K · filed 2024-03-04 | |||
| 2023-09-30 | $2.48 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | $2.20 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | $2.20 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | $3.22 10-K · filed 2023-03-06 | |||
| 2022-09-30 | $4.52 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | $4.33 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | $3.98 10-Q · filed 2022-05-06 | |||
| 2021-12-31 | $1.84 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $1.37 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | $0.77 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | $0.44 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |